A Multicohort Open-label Phase II Trial of Bipolar Androgen Therapy in Men with Metastatic Castration-resistant Prostate Cancer (RESTORE): A Comparison of Post-abiraterone Versus Post-enzalutamide Cohorts

BACKGROUND: Cyclic high-dose testosterone injections, also known as bipolar androgen therapy (BAT), is a novel treatment strategy for patients with metastatic castration-resistant prostate cancer (mCRPC). BAT has shown clinical activity in prior studies enrolling men with mCRPC and may potentially r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Markowski, Mark C., Wang, Hao, Sullivan, Rana, Rifkind, Irina, Sinibaldi, Victoria, Schweizer, Michael T., Teply, Benjamin A., Ngomba, Nduku, Fu, Wei, Carducci, Michael A., Paller, Channing J., Marshall, Catherine H., Eisenberger, Mario A., Luo, Jun, Antonarakis, Emmanuel S., Denmeade, Samuel R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7775877/
https://ncbi.nlm.nih.gov/pubmed/32624280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2020.06.042
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados